| Application no. and date | 13729089.6 (espacenet) (Federated) (European Patent Register), 20130502 | | Patent/reg. no. and date | DK/EP 2844286, 20200219 | | Publication date | 20150311 | | Priority no. and date | US 201261642644 P, 20120504 | | EP pub. no. and date |
EP 2844286 20150311 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/160543 | | Inventor | MUELLER,Claudia, Novartis Pharma AG
Werk Klybeck
Klybeckstrasse 141
CH-4057 Basel, CH,
WILLMANN, Matthias, Novartis Pharma AG
Werk Klybeck
Klybeckstrasse 141
CH-4057 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 47/28 (2006.01) , A61K 9/19 (2006.01) , C07K 16/28 (2006.01) | | Title | Lyofiliserede og vandige anti-CD40-antistofformuleringer | | Int. application no. | IB2013053490 | | Int. publication no. | WO2013164789 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
